Arkadios Wealth Advisors - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 479 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Arkadios Wealth Advisors ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2024$581,734
-21.5%
10,771
-0.9%
0.04%
-31.6%
Q1 2024$740,695
+7.3%
10,867
-1.4%
0.06%
-1.7%
Q4 2023$690,165
+35.0%
11,025
-2.1%
0.06%
+20.8%
Q3 2023$511,091
-18.2%
11,260
+1.2%
0.05%
-34.2%
Q2 2023$624,838
+18.2%
11,130
-4.8%
0.07%
+15.9%
Q1 2023$528,648
+10.8%
11,688
-0.4%
0.06%0.0%
Q4 2022$476,906
-44.0%
11,732
-10.0%
0.06%
-51.2%
Q3 2022$852,000
+5.8%
13,034
-1.6%
0.13%
+7.5%
Q2 2022$805,000
-3.0%
13,250
+0.2%
0.12%
+10.1%
Q1 2022$830,000
-14.5%
13,224
+3.2%
0.11%
-15.5%
Q4 2021$971,000
+5010.5%
12,820
+7441.2%
0.13%
+4200.0%
Q3 2021$19,000
-29.6%
1700.0%0.00%0.0%
Q2 2021$27,000
+440.0%
170
+400.0%
0.00%
+200.0%
Q4 2020$5,000
-99.8%
34
+70.0%
0.00%0.0%
Q3 2020$2,196,000
+20.8%
200.0%0.00%0.0%
Q2 2020$1,818,000
+114.4%
200.0%0.00%0.0%
Q1 2020$848,000200.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$37,781,00020.21%
Ariose Capital Management Ltd 37,900$2,872,0006.78%
EcoR1 Capital, LLC 1,077,483$81,652,0002.60%
NEA Management Company, LLC 1,590,002$120,490,0002.44%
ARK Investment Management 9,087,868$688,679,0002.08%
NIA IMPACT ADVISORS, LLC 62,609$3,876,0002.06%
Deuterium Capital Management, LLC 18,000$1,364,0002.02%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,200$8,192,0001.82%
PLUSTICK MANAGEMENT LLC 50,000$3,789,0001.76%
Nikko Asset Management Americas, Inc. 4,319,471$330,526,0001.74%
View complete list of CRISPR THERAPEUTICS AG shareholders